Little Rock, AR – JacksonImmunoResearch Laboratories, Inc. (JIR), a leader in the production and conjugation of affinity-purified secondary antibodies and purified immunoglobulins, is now listing over 4000 products on the Labscoop platform. JIR products are sold primarily to scientists in universities and research institutes throughout the world who are conducting research in the plant, animal, […]
Merck announced that approvals have been secured from all relevant jurisdictions for its planned acquisition of U.S.-based life science company Sigma-Aldrich. Unconditional approval from Brazil’s Council for Economic Defense (CADE), which was the final outstanding country, was received. This clearance becomes effective after a common waiting period of 15 days. It follows recently received antitrust […]
SANTA CLARA, Calif. — Affymetrix, Inc. (Nasdaq:AFFX) has announced three recipients of the 2015 United States Affymetrix Tumor Profiling Grant Program. The grant program, first launched in 2014, is designed to support translational cancer researchers in the discovery and validation of novel diagnostic, prognostic, and therapeutic biomarkers that may address an unmet clinical need. The […]
GE Healthcare Dharmacon has launched more than one million new CRISPR-Cas9 gene editing products using an advanced new algorithm to design highly functional and specific reagents targeting most human, mouse and rat genes. The new products include predesigned synthetic CRISPR RNAs (crRNAs), single guide RNA (sgRNA) lentiviral particles and pooled sgRNA lentiviral particle libraries. These […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today it has secured unconditional approval from Brazil’s Council for Economic Defense (CADE), the final outstanding approval required for the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany (the “Transaction”). This clearance, which will be effective after a waiting period of 15 days, follows recently received […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT:BTX) today announced that 27 new patents have issued during the first half of 2015 that are owned or licensed to BioTime or its subsidiaries. These new patents add to the portfolio of over 700 issued and pending patents and patent applications world wide that are owned or licensed […]
EMERYVILLE and LOS ALTOS, Calif. — Amyris, Inc. (AMRS), the industrial bioscience company, and Genome Compiler Corp., a synthetic biology platform company, today announced the availability of an open testing program for pharma and biotech companies to explore DNA design and construction solutions. The two companies announced a collaboration agreement in March 2015 to integrate […]
Jena, Germany — Endress+Hauser’s voluntary tender to the shareholders of Analytik Jena AG has been extended to 9 September 2015. The Group, which holds more than 95 percent of the German company, will continue to offer 14 euros a share The voluntary tender from Endress+Hauser was first initiated in July of this year. Following the […]
CAMBRIDGE, Mass. —– Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced the winners of its third annual G-Prize contest. Harris Wang, PhD, Assistant Professor in Systems Biology at Columbia University Medical Center, and Industrial Microbes were selected by an independent panel of judges for their forward-thinking […]
LGC has appointed Sigma-Aldrich Corporation as its sole, global distributor authorised to market and distribute off-the-shelf KASPTM Genotyping Assays, including more than 100,000 pre-designed assays for public domain human SNPs. LGC has also appointed Sigma-Aldrich as its non-exclusive distributor authorised to market and distribute KASPTM MasterMix reagents, custom KASPTM Laboratory Validated Assays and custom KASPTM […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
